Study of Price Variation of Anti-infective Eye Preparations

Authors

  • S. Shanmugam Department of Pharmaceutics, Adhiparasakthi College of Pharmacy, Melmaruvathur, Tamil Nadu, India
  • T. Vetrichelvan Department of Pharmaceutics, Adhiparasakthi College of Pharmacy, Melmaruvathur, Tamil Nadu, India
  • T. Ayyappan Department of Pharmaceutics, Adhiparasakthi College of Pharmacy, Melmaruvathur, Tamil Nadu, India

Abstract

To analyze the percentage cost variations among different brands of commonly prescribed ophthalmic drugs. The cost of different brands of commonly used ophthalmic drugs was sorted out by referring the latest Current Index of Medical Specialities, Indian Drug Review and Retail drug store. The cost of five dosage forms in INR of each brand, cost ratio and percentage cost variation ware calculated. Our study findings showed a very high fluctuation in the minimum and maximum price of ophthalmic drugs which is being manufactured by several companies across the different brands. The cost ratio was also observed to be very high. The percentage variation in the cost was above 100% with most of the commonly used ophthalmic drugs such as Aciclovir (5 mg) 36.93%, Ofloxacin (5 ml) 120.55%, Moxifloxacin (5 ml) 248.16%, Gentamicin (5 ml) 135.25% and Chloramphenicol (5 ml) 260%.

 

Keywords: Price variation, eye preparation, marketed formulation

Cite this Article

ShanmugamS, VetrichelvanT, Ayyappan T. Study of Price Variation of Anti-infective Eye Preparations. Research & Reviews: A Journal of Drug Design & Discovery. 2018; 5(2): 10–12p.

Downloads

Published

2018-11-01

Issue

Vol. 5 No. 2 (2018)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.